Lexicon Pharmaceuticals, INC. (LXRX) — SC 13D/A Filings
All SC 13D/A filings from Lexicon Pharmaceuticals, INC.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
Invus Group Amends Lexicon Pharma Stake Filing
— Dec 9, 2024 Risk: medium
Invus, L.P. and its affiliates have filed a Schedule 13D/A amendment on December 9, 2024, regarding their holdings in Lexicon Pharmaceuticals, Inc. The filing i -
Invus L.P. Amends Lexicon Pharmaceuticals Stake Filing
— Jul 29, 2024 Risk: medium
Invus, L.P. filed an amendment to its Schedule 13D on July 29, 2024, regarding its beneficial ownership of Lexicon Pharmaceuticals, Inc. The filing indicates a -
Invus L.P. Amends Lexicon Pharmaceuticals Stake
— May 14, 2024 Risk: medium
On May 14, 2024, Invus, L.P. filed an amendment to its Schedule 13D, disclosing its beneficial ownership of Lexicon Pharmaceuticals, Inc. The filing indicates a -
Invus L.P. Amends Stake in Lexicon Pharmaceuticals
— Mar 13, 2024 Risk: medium
On March 13, 2024, Invus, L.P. filed an amendment to its Schedule 13D, reporting a change in beneficial ownership of Lexicon Pharmaceuticals, Inc. The filing in
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX